Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma
BelgiumStudy Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant
CzechiaStudy of Ibrutinib and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma
CzechiaStudy of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment
CzechiaStudy on JDQ443 for Patients with KRAS G12C+ Non-Small Cell Lung Cancer and Brain Metastases
The NetherlandsStudy of Durvalumab and Tremelimumab with Y-90 SIRT Therapy for Patients with Advanced Intrahepatic Biliary Tract Cancer
GermanyStudy on Triple Negative Breast Cancer Treatment with Chemotherapy, Fasting-Mimicking Diet, and Metformin for Preoperative Patients
ItalyStudy Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy on Budesonide Tablets for Preventing Esophageal Narrowing in Adults After Cancer Tissue Removal
FranceStudy of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy
FranceStudy of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer
FranceStudy of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer
BelgiumThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
